New York Health Care (OTCMKTS:BBAL) and BioScrip (NASDAQ:BIOS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.
Institutional & Insider Ownership
82.1% of BioScrip shares are owned by institutional investors. 6.7% of New York Health Care shares are owned by company insiders. Comparatively, 0.8% of BioScrip shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Volatility and Risk
New York Health Care has a beta of -1.43, suggesting that its stock price is 243% less volatile than the S&P 500. Comparatively, BioScrip has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500.
This is a breakdown of recent recommendations and price targets for New York Health Care and BioScrip, as reported by MarketBeat.
BioScrip has a consensus target price of $3.58, indicating a potential downside of 4.95%. Given BioScrip’s higher probable upside, analysts clearly believe BioScrip is more favorable than New York Health Care.
Valuation and Earnings
This table compares New York Health Care and BioScrip’s gross revenue, earnings per share (EPS) and valuation.
New York Health Care has higher earnings, but lower revenue than BioScrip.
This table compares New York Health Care and BioScrip’s net margins, return on equity and return on assets.
BioScrip beats New York Health Care on 5 of the 8 factors compared between the two stocks.
New York Health Care Company Profile
New York Health Care, Inc. operates as a home care services agency primarily in New York. The company offers various home care services, such as companionship services, homemaker/housekeeper staff, professional and practical nurses, home health aides, care givers, geriatric care, and dementia and alzheimer care services. It also provides insurance services. The company was founded in 1983 and is based in Valley Stream, New York.
BioScrip Company Profile
BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient's homes, outpatient clinics, nursing facilities, physician's offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.